Annual EBIT
-$21.43 M
+$150.00 K+0.70%
31 December 2023
Summary:
Theriva Biologics annual earnings before interest & taxes is currently -$21.43 million, with the most recent change of +$150.00 thousand (+0.70%) on 31 December 2023. During the last 3 years, it has fallen by -$11.27 million (-110.94%). TOVX annual EBIT is now -1878.86% below its all-time high of -$737.00 thousand.TOVX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$5.04 M
-$616.00 K-13.94%
01 September 2024
Summary:
Theriva Biologics quarterly earnings before interest & taxes is currently -$5.04 million, with the most recent change of -$616.00 thousand (-13.94%) on 01 September 2024. Over the past year, it has dropped by -$818.00 thousand (-19.39%). TOVX quarterly EBIT is now -617.41% below its all-time high of $973.30 thousand, reached on 01 June 2010.TOVX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$21.07 M
-$818.00 K-4.04%
01 September 2024
Summary:
Theriva Biologics TTM earnings before interest & taxes is currently -$21.07 million, with the most recent change of -$818.00 thousand (-4.04%) on 01 September 2024. Over the past year, it has increased by +$1.47 million (+6.51%). TOVX TTM EBIT is now -6921.67% below its all-time high of -$300.00 thousand, reached on 01 March 1993.TOVX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TOVX EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +0.7% | -19.4% | +6.5% |
| 3 y3 years | -110.9% | +4.3% | -47.6% |
| 5 y5 years | -36.8% | -56.9% | -34.5% |
TOVX EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -110.9% | +0.7% | -19.4% | +31.2% | -47.6% | +9.6% |
| 5 y | 5 years | -110.9% | +0.7% | -138.6% | +31.2% | -117.9% | +9.6% |
| alltime | all time | -1878.9% | +47.7% | -617.4% | +57.6% | -6921.7% | +51.4% |
Theriva Biologics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$5.04 M(+13.9%) | -$21.07 M(+4.0%) |
| June 2024 | - | -$4.42 M(-18.0%) | -$20.25 M(-6.5%) |
| Mar 2024 | - | -$5.39 M(-13.3%) | -$21.65 M(+1.0%) |
| Dec 2023 | -$21.43 M(-0.7%) | -$6.22 M(+47.4%) | -$21.43 M(-4.9%) |
| Sept 2023 | - | -$4.22 M(-27.5%) | -$22.53 M(-3.3%) |
| June 2023 | - | -$5.82 M(+12.4%) | -$23.30 M(+3.5%) |
| Mar 2023 | - | -$5.18 M(-29.2%) | -$22.51 M(+4.3%) |
| Dec 2022 | -$21.58 M(+51.2%) | -$7.32 M(+46.8%) | -$21.58 M(+10.5%) |
| Sept 2022 | - | -$4.99 M(-0.8%) | -$19.53 M(+9.6%) |
| June 2022 | - | -$5.03 M(+18.2%) | -$17.82 M(+11.4%) |
| Mar 2022 | - | -$4.25 M(-19.2%) | -$15.99 M(+12.0%) |
| Dec 2021 | -$14.27 M(+40.5%) | - | - |
| Dec 2021 | - | -$5.26 M(+60.8%) | -$14.27 M(+28.1%) |
| Sept 2021 | - | -$3.27 M(+2.4%) | -$11.14 M(+11.7%) |
| June 2021 | - | -$3.20 M(+26.0%) | -$9.98 M(+3.2%) |
| Mar 2021 | - | -$2.54 M(+19.0%) | -$9.67 M(-4.8%) |
| Dec 2020 | -$10.16 M(-35.1%) | -$2.13 M(+1.0%) | -$10.16 M(-9.6%) |
| Sept 2020 | - | -$2.11 M(-26.9%) | -$11.24 M(-21.8%) |
| June 2020 | - | -$2.89 M(-4.6%) | -$14.37 M(-5.0%) |
| Mar 2020 | - | -$3.03 M(-5.7%) | -$15.12 M(-3.5%) |
| Dec 2019 | -$15.66 M(-10.9%) | -$3.21 M(-38.8%) | -$15.66 M(-0.3%) |
| Sept 2019 | - | -$5.24 M(+44.1%) | -$15.71 M(+6.2%) |
| June 2019 | - | -$3.64 M(+1.8%) | -$14.79 M(-8.5%) |
| Mar 2019 | - | -$3.57 M(+9.6%) | -$16.15 M(-8.1%) |
| Dec 2018 | -$17.57 M(-33.1%) | -$3.26 M(-24.6%) | -$17.57 M(-12.6%) |
| Sept 2018 | - | -$4.32 M(-13.7%) | -$20.10 M(-7.0%) |
| June 2018 | - | -$5.00 M(+0.3%) | -$21.62 M(-6.4%) |
| Mar 2018 | - | -$4.99 M(-13.7%) | -$23.09 M(-12.0%) |
| Dec 2017 | -$26.25 M(-33.1%) | -$5.78 M(-1.0%) | -$26.25 M(-14.4%) |
| Sept 2017 | - | -$5.84 M(-9.8%) | -$30.67 M(-9.8%) |
| June 2017 | - | -$6.47 M(-20.5%) | -$33.98 M(-7.7%) |
| Mar 2017 | - | -$8.15 M(-20.1%) | -$36.82 M(-6.2%) |
| Dec 2016 | -$39.25 M(-4.2%) | -$10.20 M(+11.4%) | -$39.25 M(-2.9%) |
| Sept 2016 | - | -$9.16 M(-1.7%) | -$40.44 M(-5.8%) |
| June 2016 | - | -$9.31 M(-12.0%) | -$42.94 M(-1.0%) |
| Mar 2016 | - | -$10.58 M(-7.1%) | -$43.35 M(+5.8%) |
| Dec 2015 | -$40.98 M(+99.9%) | -$11.39 M(-2.2%) | -$40.98 M(+11.7%) |
| Sept 2015 | - | -$11.65 M(+19.7%) | -$36.69 M(+22.5%) |
| June 2015 | - | -$9.73 M(+18.6%) | -$29.95 M(+20.4%) |
| Mar 2015 | - | -$8.21 M(+15.6%) | -$24.87 M(+21.3%) |
| Dec 2014 | -$20.50 M(+66.2%) | -$7.10 M(+44.6%) | -$20.50 M(+16.0%) |
| Sept 2014 | - | -$4.91 M(+5.6%) | -$17.67 M(+9.6%) |
| June 2014 | - | -$4.65 M(+21.2%) | -$16.13 M(+15.7%) |
| Mar 2014 | - | -$3.84 M(-10.2%) | -$13.94 M(+13.0%) |
| Dec 2013 | -$12.34 M(-28.7%) | -$4.27 M(+27.0%) | -$12.34 M(-38.2%) |
| Sept 2013 | - | -$3.37 M(+36.7%) | -$19.95 M(+8.3%) |
| June 2013 | - | -$2.46 M(+9.9%) | -$18.42 M(+4.2%) |
| Mar 2013 | - | -$2.24 M(-81.2%) | -$17.68 M(+2.2%) |
| Dec 2012 | -$17.30 M(+191.8%) | -$11.89 M(+547.4%) | -$17.30 M(+110.9%) |
| Sept 2012 | - | -$1.84 M(+6.6%) | -$8.20 M(+13.3%) |
| June 2012 | - | -$1.72 M(-7.1%) | -$7.24 M(+14.5%) |
| Mar 2012 | - | -$1.85 M(-33.5%) | -$6.32 M(+6.6%) |
| Dec 2011 | -$5.93 M(+447.4%) | -$2.79 M(+220.1%) | -$5.93 M(+75.7%) |
| Sept 2011 | - | -$871.00 K(+8.2%) | -$3.37 M(+4.3%) |
| June 2011 | - | -$805.00 K(-45.0%) | -$3.24 M(+121.9%) |
| Mar 2011 | - | -$1.46 M(+523.5%) | -$1.46 M(+33.9%) |
| Dec 2010 | -$1.08 M | -$234.80 K(-68.0%) | -$1.09 M(-44.3%) |
| Sept 2010 | - | -$733.10 K(-175.3%) | -$1.96 M(+5.8%) |
| June 2010 | - | $973.30 K(-188.9%) | -$1.85 M(-50.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2010 | - | -$1.09 M(-0.6%) | -$3.70 M(+0.1%) |
| Dec 2009 | -$3.72 M(-49.2%) | -$1.10 M(+75.8%) | -$3.70 M(+5.1%) |
| Sept 2009 | - | -$626.20 K(-28.8%) | -$3.52 M(-19.4%) |
| June 2009 | - | -$879.60 K(-19.3%) | -$4.36 M(-17.5%) |
| Mar 2009 | - | -$1.09 M(+18.4%) | -$5.28 M(-27.8%) |
| Dec 2008 | -$7.32 M(-27.8%) | -$920.10 K(-37.4%) | -$7.32 M(-23.9%) |
| Sept 2008 | - | -$1.47 M(-18.4%) | -$9.62 M(-6.8%) |
| June 2008 | - | -$1.80 M(-42.4%) | -$10.32 M(-0.3%) |
| Mar 2008 | - | -$3.13 M(-2.8%) | -$10.34 M(+2.0%) |
| Dec 2007 | -$10.14 M(+147.0%) | -$3.22 M(+48.0%) | -$10.14 M(+12.2%) |
| Sept 2007 | - | -$2.17 M(+18.9%) | -$9.04 M(+18.6%) |
| June 2007 | - | -$1.83 M(-37.4%) | -$7.62 M(+17.1%) |
| Mar 2007 | - | -$2.92 M(+38.1%) | -$6.51 M(+58.6%) |
| Dec 2006 | -$4.10 M(+211.1%) | -$2.12 M(+179.2%) | -$4.10 M(+106.3%) |
| Sept 2006 | - | -$757.60 K(+5.8%) | -$1.99 M(+61.5%) |
| June 2006 | - | -$716.20 K(+38.9%) | -$1.23 M(+138.9%) |
| Mar 2006 | - | -$515.50 K(-14.7%) | -$515.50 K(-91.0%) |
| Dec 2005 | -$1.32 M(-84.0%) | - | - |
| Mar 2003 | - | -$604.40 K(-28.5%) | -$5.72 M(-30.6%) |
| Dec 2002 | -$8.25 M(-15.9%) | -$845.20 K(-28.2%) | -$8.25 M(-20.8%) |
| Sept 2002 | - | -$1.18 M(-61.9%) | -$10.41 M(-13.1%) |
| June 2002 | - | -$3.09 M(-1.2%) | -$11.99 M(+6.2%) |
| Mar 2002 | - | -$3.13 M(+4.0%) | -$11.29 M(-40.4%) |
| Dec 2001 | -$9.81 M(+55.8%) | -$3.01 M(+9.4%) | -$18.94 M(+6.8%) |
| Sept 2001 | - | -$2.75 M(+14.9%) | -$17.74 M(+8.0%) |
| June 2001 | - | -$2.39 M(-77.8%) | -$16.43 M(+5.7%) |
| Mar 2001 | - | -$10.79 M(+495.9%) | -$15.55 M(+146.9%) |
| Dec 2000 | -$6.30 M(+15.1%) | -$1.81 M(+26.2%) | -$6.30 M(+5.7%) |
| Sept 2000 | - | -$1.43 M(-5.3%) | -$5.96 M(-1.1%) |
| June 2000 | - | -$1.51 M(-1.5%) | -$6.02 M(+3.2%) |
| Mar 2000 | - | -$1.54 M(+4.4%) | -$5.84 M(+6.2%) |
| Dec 1999 | -$5.47 M(+4.2%) | -$1.47 M(-1.9%) | -$5.50 M(+6.2%) |
| Sept 1999 | - | -$1.50 M(+12.8%) | -$5.17 M(+8.4%) |
| June 1999 | - | -$1.33 M(+11.4%) | -$4.77 M(+15.2%) |
| Mar 1999 | - | -$1.19 M(+3.9%) | -$4.14 M(-17.9%) |
| Dec 1998 | -$5.25 M(-34.4%) | -$1.15 M(+4.5%) | -$5.05 M(+32.9%) |
| Sept 1998 | - | -$1.10 M(+57.1%) | -$3.80 M(-15.6%) |
| June 1998 | - | -$700.00 K(-66.7%) | -$4.50 M(-36.6%) |
| Mar 1998 | - | -$2.10 M(-2200.0%) | -$7.10 M(-6.6%) |
| Dec 1997 | -$8.00 M(+8.1%) | $100.00 K(-105.6%) | -$7.60 M(-24.0%) |
| Sept 1997 | - | -$1.80 M(-45.5%) | -$10.00 M(+1.0%) |
| June 1997 | - | -$3.30 M(+26.9%) | -$9.90 M(+20.7%) |
| Mar 1997 | - | -$2.60 M(+13.0%) | -$8.20 M(+13.9%) |
| Dec 1996 | -$7.40 M(+1.4%) | -$2.30 M(+35.3%) | -$7.20 M(+5.9%) |
| Sept 1996 | - | -$1.70 M(+6.3%) | -$6.80 M(-4.2%) |
| June 1996 | - | -$1.60 M(0.0%) | -$7.10 M(+31.5%) |
| Mar 1996 | - | -$1.60 M(-15.8%) | -$5.40 M(+45.9%) |
| Dec 1995 | -$7.30 M(+15.9%) | -$1.90 M(-5.0%) | -$3.70 M(-54.9%) |
| Sept 1995 | - | -$2.00 M(-2100.0%) | -$8.20 M(+34.4%) |
| June 1995 | - | $100.00 K(0.0%) | -$6.10 M(0.0%) |
| Mar 1995 | - | $100.00 K(-101.6%) | -$6.10 M(-6.2%) |
| Dec 1994 | -$6.30 M(+70.3%) | -$6.40 M(-6500.0%) | -$6.50 M(+400.0%) |
| Sept 1994 | - | $100.00 K(0.0%) | -$1.30 M(-53.6%) |
| June 1994 | - | $100.00 K(-133.3%) | -$2.80 M(-15.2%) |
| Mar 1994 | - | -$300.00 K(-75.0%) | -$3.30 M(0.0%) |
| Dec 1993 | -$3.70 M | -$1.20 M(-14.3%) | -$3.30 M(+57.1%) |
| Sept 1993 | - | -$1.40 M(+250.0%) | -$2.10 M(+200.0%) |
| June 1993 | - | -$400.00 K(+33.3%) | -$700.00 K(+133.3%) |
| Mar 1993 | - | -$300.00 K | -$300.00 K |
FAQ
- What is Theriva Biologics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Theriva Biologics?
- What is Theriva Biologics annual EBIT year-on-year change?
- What is Theriva Biologics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Theriva Biologics?
- What is Theriva Biologics quarterly EBIT year-on-year change?
- What is Theriva Biologics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Theriva Biologics?
- What is Theriva Biologics TTM EBIT year-on-year change?
What is Theriva Biologics annual earnings before interest & taxes?
The current annual EBIT of TOVX is -$21.43 M
What is the all time high annual EBIT for Theriva Biologics?
Theriva Biologics all-time high annual earnings before interest & taxes is -$737.00 K
What is Theriva Biologics annual EBIT year-on-year change?
Over the past year, TOVX annual earnings before interest & taxes has changed by +$150.00 K (+0.70%)
What is Theriva Biologics quarterly earnings before interest & taxes?
The current quarterly EBIT of TOVX is -$5.04 M
What is the all time high quarterly EBIT for Theriva Biologics?
Theriva Biologics all-time high quarterly earnings before interest & taxes is $973.30 K
What is Theriva Biologics quarterly EBIT year-on-year change?
Over the past year, TOVX quarterly earnings before interest & taxes has changed by -$818.00 K (-19.39%)
What is Theriva Biologics TTM earnings before interest & taxes?
The current TTM EBIT of TOVX is -$21.07 M
What is the all time high TTM EBIT for Theriva Biologics?
Theriva Biologics all-time high TTM earnings before interest & taxes is -$300.00 K
What is Theriva Biologics TTM EBIT year-on-year change?
Over the past year, TOVX TTM earnings before interest & taxes has changed by +$1.47 M (+6.51%)